Related Experiment Video

Updated: Aug 24, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Analysis of nonintervention strategy for in-stent restenosis in Pauci- or asymptomatic patients

Hélène Eltchaninoff1, Raphaëlle Carlot, Christophe Tron

  • 1Charles Nicolle Hospital, University of Rouen, Rouen, France. helene.eltchaninoff@chu-rouen.fr

The American Journal of Cardiology
|April 15, 2004
PubMed

Insights

Medical treatment alone is effective for selected patients with in-stent restenosis, showing good long-term outcomes. This approach avoids repeat procedures and adverse cardiac events in many cases.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Medicine

Background:

  • In-stent restenosis (ISR) is a significant complication after coronary stenting.
  • Optimal management for ISR without revascularization remains an area of interest.
  • Medical therapy alone is an alternative for select ISR patients.

Purpose of the Study:

  • To evaluate the long-term clinical outcomes of patients with in-stent restenosis treated with medical therapy alone.
  • To assess the safety and efficacy of conservative management for ISR.

Main Methods:

  • Retrospective identification of 66 patients with in-stent restenosis between January 1996 and May 2000.
  • Patients were managed with medical treatment exclusively, without percutaneous coronary intervention or bypass surgery.
  • Clinical follow-up data were analyzed at 33 +/- 11 months.

Main Results:

  • 86% of patients had diffuse or proliferative in-stent restenosis.
  • At follow-up, 2 patients died (3%), and none experienced myocardial infarction.
  • Only 6% of patients required target lesion revascularization (repeat percutaneous transluminal coronary angioplasty).

Conclusions:

  • Medical treatment alone can be associated with good long-term clinical follow-up in carefully selected patients with significant in-stent restenosis.
  • Conservative management may reduce the need for repeat interventions and adverse cardiovascular events.
  • This strategy offers a viable option for specific patient cohorts with ISR.

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...